×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| PHARMAIDS PHARMACEUTICALS LTD. | NA | NA | NA | NA | 204.0 | |
| ALPA LABORATORIES LTD. | 310.69 | 117.76 | 191.11 | 5.6 | 200 | 7.63 |
| AAREY DRUGS & PHARMACEUTICALS | 1037.6 | 13.71 | 1022.08 | 0.48 | 198 | 47.7 |
Pharmaids Pharmaceuticals Ltd., with Security Code 524572, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.8 | 1.2 | 0.1 |
| Expenses | 0.7 | 8.6 | 1.6 | 1.0 | 1.3 | 1.8 | 1.9 | 2.0 | 2.9 | 2.8 |
| Operating Profit | -0.7 | -8.6 | -1.6 | -1.0 | -1.3 | -1.8 | -1.7 | -1.1 | -1.7 | -2.7 |
| OPM % | 0% | 0% | 0% | 0% | -6166.67% | -25814.29% | -1027.54% | -135.37% | -143.13% | -2000% |
| Other Income | 0.0 | 0.0 | 0.4 | -0.3 | -0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.1 | 2.1 |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 |
| Profit before tax | -0.7 | -8.6 | -1.2 | -1.3 | -2.2 | -2.1 | -1.8 | -1.2 | -1.8 | -3.8 |
| Tax % | 0.4% | -28.4% | 7.8% | -60.8% | -26.1% | 6.1% | -8.5% | -15.2% | -13.7% | 0% |
| Net Profit | -0.7 | -6.2 | -1.3 | -0.5 | -1.6 | -2.2 | -1.6 | -1.0 | -1.6 | -3.1 |
| EPS in Rs | -0.5 | -4.79 | -0.58 | -0.23 | -0.73 | -0.99 | -0.46 | -0.29 | -0.45 | 0 |
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.0 | 0.0 | 0.0 | 0.0 | 5.8 | 4.7 | 5.2 | 4.7 | 4.8 |
| Expenses | 8.6 | 1.6 | 1.0 | 1.3 | 11.4 | 8.1 | 7.8 | 7.6 | 8.7 |
| Operating Profit | -8.6 | -1.6 | -1.0 | -1.3 | -5.6 | -3.4 | -2.6 | -2.9 | -3.9 |
| OPM % | 0% | 0% | 0% | -6166.67% | -96.09% | -72.88% | -48.81% | -61.27% | -81.88% |
| Other Income | 0.0 | 0.4 | -0.3 | -0.9 | 0.1 | -0.1 | -0.1 | 0.0 | 0.1 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 0.3 | 0.3 | 0.5 | 1.0 |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 |
| Profit before tax | -8.6 | -1.2 | -1.3 | -2.2 | -6.9 | -4.2 | -3.5 | -4.0 | -5.5 |
| Tax % | -28.4% | 7.8% | -60.8% | -26.1% | -7.8% | -27.4% | -28.1% | -24.9% | 0% |
| Net Profit | -6.2 | -1.3 | -0.5 | -1.6 | -6.3 | -3.1 | -2.6 | -3.0 | -4.8 |
| EPS in Rs | -4.76 | -0.58 | -0.23 | -0.73 | -2.82 | -0.76 | -0.73 | -0.55 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -32% |
| 5 Years: | -44% |
| 3 Years: | -85% |
| TTM: | 11000% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 67% |
| 3 Years: | 77% |
| 1 Year: | 11% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 102050% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -34% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 67% |
| 3 Years: | 77% |
| 1 Year: | 11% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|